Mono Antiplatelet and Colchicine Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT04949516

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04949516
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04949516. Allocation not applicable; no masking; primary purpose treatment. Start 2021-06-15 (actual); primary completion 2022-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mono Antiplatelet and Colchicine Therapy
Acronym
MACT
Condition
Acute Coronary Syndrome
Condition
Drug-Eluting Stents
Intervention (Drug)
Aspirin
Intervention (Drug)
Colchicine
Lead sponsor
Wonkwang University Hospital (class: other)

Record details

Record id
cardio:ct-nct04949516
Content hash
4d8fd2bbbd10bbe46b25c7e025da8c1809962da6b2f44b955cd33f64bb05e392